TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (TCRX)
CUSIP: 89854M101
Q4 2022 13F Holders as of 31 Dec 2022
- Type / Class
- Equity / Voting Common Stock, par value $0.0001 per share
- Shares outstanding
- 52,382,313
- Total 13F shares
- 9,519,305
- Share change
- +11,213
- Total reported value
- $14,788,379
- Price per share
- $1.55
- Number of holders
- 28
- Value change
- -$121,391
- Number of buys
- 12
- Number of sells
- 6
Quarterly Holders Quick Answers
What is CUSIP 89854M101?
CUSIP 89854M101 identifies TCRX - TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 89854M101:
Top shareholders of TCRX - TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Christoph H. Westphal |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,193,472
|
$10,898,266 | — | 20 Jul 2021 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
5.3%
|
2,784,792
|
$8,494,000 | — | 30 Sep 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.9%
|
1,513,815
|
$4,617,000 | — | 30 Sep 2022 | |
| Deer Management Co. LLC |
13F
|
Company |
2.4%
|
1,245,505
|
$3,799,000 | — | 30 Sep 2022 | |
| Alphabet Inc. |
13F
|
Company |
2.1%
|
1,077,080
|
$3,285,000 | — | 30 Sep 2022 | |
| DC Funds, LP |
13F
|
Company |
1.2%
|
630,000
|
$1,922,000 | — | 30 Sep 2022 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.1%
|
557,915
|
$1,702,000 | — | 30 Sep 2022 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1%
|
550,000
|
$1,678,000 | — | 30 Sep 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.49%
|
257,416
|
$785,000 | — | 30 Sep 2022 | |
| Newtyn Management, LLC |
13F
|
Company |
0.38%
|
200,000
|
$610,000 | — | 30 Sep 2022 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.38%
|
200,000
|
$610,000 | — | 30 Sep 2022 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.22%
|
115,000
|
$351,000 | — | 30 Sep 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.19%
|
100,669
|
$307,000 | — | 30 Sep 2022 | |
| Woodline Partners LP |
13F
|
Company |
0.13%
|
66,601
|
$203,000 | — | 30 Sep 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.12%
|
64,570
|
$197,000 | — | 30 Sep 2022 | |
| DC Investments Management, LLC |
13F
|
Company |
0.07%
|
35,563
|
$110,000 | — | 30 Sep 2022 | |
| Marquette Asset Management, LLC |
13F
|
Company |
0.06%
|
28,895
|
$88,000 | — | 30 Sep 2022 | |
| Privium Fund Management (UK) Ltd |
13F
|
Company |
0.03%
|
15,825
|
$48,000 | — | 30 Sep 2022 | |
| LPL Financial LLC |
13F
|
Company |
0.03%
|
15,000
|
$46,000 | — | 30 Sep 2022 | |
| CANNELL CAPITAL LLC |
13F
|
Company |
0.03%
|
14,666
|
$45,000 | — | 30 Sep 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.03%
|
13,400
|
$41,000 | — | 30 Sep 2022 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.02%
|
11,000
|
$34,000 | — | 30 Sep 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
6,043
|
$18,000 | — | 30 Sep 2022 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
3,441
|
$11,000 | — | 30 Sep 2022 | |
| ATLAS CAPITAL ADVISORS INC. |
13F
|
Company |
0%
|
896
|
$2,732 | — | 30 Sep 2022 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
184
|
$1,000 | — | 30 Sep 2022 | |
| William Desmarais |
3/4/5
|
Chief Business Officer |
—
class O/S missing
|
30,000
|
— | — | 25 Jul 2022 | |
| Ittai Harel |
3/4/5
|
Director |
—
class O/S missing
|
9,146
|
— | — | 01 Jun 2022 |
Institutional Holders of TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (TCRX) as of Q4 2022
As of 31 Dec 2022,
TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (TCRX) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,519,305 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, BlackRock Inc., Deer Management Co. LLC, Alphabet Inc., DC Funds, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., TANG CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, Newtyn Management, LLC, and Tekla Capital Management LLC.
This page lists
28
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
24
Q4 2022 holders
28
Holder diff
4
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 Value $ | Q4 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.